- Interim results of the Oxford COVID-19 vaccine trials find that it protects against symptomatic disease in 70% of cases - with vaccine efficacy of 62% for those given two full doses, and of 90% in those given a half then a full dose. No hospitalisations reported in the COVID-19 vaccine group so far https://www.eurekalert.org/pub_releases/2020-12/tl-pss120820.php 8 comments science
Linked pages
Related searches:
Search whole site: site:eurekalert.org
Search title: The Lancet: Oxford COVID-19 vaccine is safe a | EurekAlert!
See how to search.